news bytes
PANACEA BIOTEC ANNOUNCES
JOINT COLLABORATION WITH
BIOPHARMA INC
One of
India’s
leading
vaccine
companies,
the Panacea
Biotec has
entered into a joint collaboration
for the development, license,
manufacturing, supply, and sales of
7 complex generic pharmaceutical
products with Biopharma Inc, a
generic pharmaceutical company
based in the United States. The
Panacea Biotec has been so far
mainly recognized as a vaccine
manufacturer and with this step,
it seems to have taken another
big leap into biopharmaceutical
manufacturing and sales.
The joint collaboration between
two companies has been
established for the research,
development and manufacturing
activities for commercialization
of 7 Abbreviated New Drug
Applications (ANDAs), which are
currently under development at
Panacea Biotec, representing a
total estimated market potential
of more than USD 800 million.
88
BioVoiceNews | August 2017
Under the collaboration, Panacea
Biotec will be responsible for
development, filing, registration
and manufacturing and supply of
these ANDAs. Biopharma Inc will
be responsible for the importation,
warehousing, sales and distribution
of these ANDAs in the United
States and its territories.
GOVT TO PROMOTE BAMBOO AS
SOURCE OF BIOFUEL
The
Government is
soon likely to
bring a policy
to promote
bamboo
sector which
could be used to harness bio-fuel,
revealed the Union Road Transport,
Highways and Shipping Minister,
Mr Nitin Gadkari at an event in
New Delhi recently.
“I have been very diligently
working towards diversification of
agriculture into energy and power
sector, I am happy to inform that I
aggressively followed up with the
matter and held three meetings
with the Prime Minister’s Office
(PMO) and soon we will have a
bamboo policy,” said Mr Gadkari
while addressing an ASSOCHAM